Urovant licenses novel gene therapy for overactive bladder
World | News | 0 Comment | 28 Aug, 2018
Singapore - Urovant Sciences, a clinical-stage biopharmaceutical company focused on developing therapies for urologic co...Read more
Patrys, Walter and Eliza Hall awarded grant
World | News | 0 Comment | 28 Aug, 2018
Singapore - Patrys Limited and the Walter and Eliza Hall Institute of Medical Research have recently been awarded a...Read more
Eisai announces long-term cardiovascular outcomes data for anti-obesity Agent
World | News | 0 Comment | 28 Aug, 2018
Eisai Inc. recently announced that results from the CAMELLIA-TIMI 61 cardiovascular (CV) outcomes trial in patients trea...Read more
Study reveals reasons of death after non-cardiac surgery
World | News | 0 Comment | 28 Aug, 2018
The main reasons why people die after non-cardiac surgery are revealed in a study of more than 40,000 patients from six ...Read more
Researchers find new blood clot prevention strategy
World | News | 0 Comment | 27 Aug, 2018
Feinstein Institute for Medical Research Professor Alex C. Spyropoulos, MD, has uncovered an anticoagulant treatment str...Read more
BHF launches £30 M funding for cardiovascular research
World | News | 0 Comment | 27 Aug, 2018
The British Heart Foundation (BHF) has launched the Big Beat Challenge, a unique research funding award that will bring ...Read more
Shire receives USFDA nod for TAKHZYRO
World | News | 0 Comment | 27 Aug, 2018
Shire, the leading global biotechnology company focused on rare diseases, has announced that following priority review, ...Read more
GT Biopharma appoints David Cardino as VP, Finance
World | News | 0 Comment | 24 Aug, 2018
GT Biopharma Inc. (GTBP) an immuno-oncology biotechnology company focused on innovative treatments based on the company'...Read more
Facebook, NYU to initiate fastMRI using AI
World | News | 0 Comment | 24 Aug, 2018
Facebook has partnered with New York University (NYU) School of Medicine to initiate a research project focused on lever...Read more
FDA approves first drug for neurotrophic keratitis
World | News | 0 Comment | 23 Aug, 2018
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...Read more
World | News | 0 Comment | 23 Aug, 2018
Singapore- DexCom, leader in continuous glucose monitoring for people with diabetes, announced today that it has acquire...Read more
Bluebird, Gritstone inks deal to develop cancer cell therapies
World | News | 0 Comment | 23 Aug, 2018
Singapore- Bluebird Bio and Gritstone Oncology collaborates to research, develop and commercialize products for the trea...Read more
Philips introduces new cardiovascular ultrasound system
World | News | 0 Comment | 23 Aug, 2018
Royal Philips, a global leader in health technology, has introduced the EPIQ CVx cardiovascular ultrasound system. Built...Read more
GIC receives govt funding for immuno-oncology project
World | News | 0 Comment | 22 Aug, 2018
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...Read more
World | News | 0 Comment | 21 Aug, 2018
Singapore - Achillion Pharmaceuticals appoints Steven Zelenkofske, D.O. to the position of Executive Vice President...Read more
Researchers develop predictor for immunotherapy response in melanoma
World | News | 0 Comment | 21 Aug, 2018
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patie...Read more
FDA grants orphan drug status to ASLAN’s treatment for AML
World | News | 0 Comment | 20 Aug, 2018
Singapore - ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly pre...Read more
Tolero Pharmaceuticals collaborates with AbbVie for AML trial
World | News | 0 Comment | 20 Aug, 2018
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...Read more